Position in OCGN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$13,177,379
+$6,630,753 QoQ
Shares Held
7,280,320
+50.1% QoQ
Ownership
2.15%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Derivatives in OCGN
reported options exposure · as of Jun 30, 2021CallValue
$0
CallShares
0
PutValue
$17,989,609
PutShares
2,240,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $7,582,717,950 across 563 Biotechnology names. OCGN ranks #78 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,374 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,698 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,893 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,161 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,774 | |
| 8 | MRNA |
Moderna, Inc.
|
4,407,907 | $223,921,675 |
All Filings in OCGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,177,379 | 7,280,320 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $6,546,626 | 4,849,353 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $1,670,552 | 1,024,879 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $634,747 | 654,379 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,083,652 | 4,367,780 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $784,584 | 974,643 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $564,314 | 568,867 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $717,395 | 462,836 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $23,260 | 14,184 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,187 | 3,805 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $9,736 | 24,341 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $4,901 | 9,027 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $88,726 | 104,019 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,043,652 | 1,572,040 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $513,620 | 288,551 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,983,964 | 873,993 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $7,032,544 | 2,131,074 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,757,507 | 825,826 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,041,439 | 423,599 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $17,989,609 | 2,240,300 | Put | Defined | 2021-08-13 | |
| 2021-06-30 | $409,449 | 50,990 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $942,485 | 138,805 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $75 | 41 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $24,877 | 80,253 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $39,399 | 179,091 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $4,727 | 16,825 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||